Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 12 | 2022 | 2019 | 0.910 |
Why?
|
Transplantation Tolerance | 3 | 2019 | 614 | 0.690 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2020 | 2091 | 0.320 |
Why?
|
Reperfusion Injury | 4 | 2015 | 1067 | 0.290 |
Why?
|
Liver Neoplasms | 4 | 2020 | 4102 | 0.250 |
Why?
|
Cold Ischemia | 2 | 2013 | 60 | 0.220 |
Why?
|
Mice, Inbred C3H | 2 | 2021 | 1013 | 0.220 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 32 | 0.200 |
Why?
|
Hepatectomy | 2 | 2020 | 563 | 0.190 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2021 | 3045 | 0.190 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2022 | 248 | 0.190 |
Why?
|
Liver | 6 | 2022 | 7594 | 0.140 |
Why?
|
Interleukin-15 Receptor alpha Subunit | 1 | 2015 | 2 | 0.140 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2015 | 72 | 0.140 |
Why?
|
Cholangiocarcinoma | 1 | 2020 | 525 | 0.140 |
Why?
|
Interleukin-15 | 1 | 2015 | 162 | 0.130 |
Why?
|
Waiting Lists | 1 | 2018 | 715 | 0.120 |
Why?
|
Warm Ischemia | 1 | 2013 | 51 | 0.120 |
Why?
|
Kupffer Cells | 1 | 2012 | 158 | 0.110 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6641 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1005 | 0.110 |
Why?
|
Dendritic Cells | 4 | 2021 | 2699 | 0.100 |
Why?
|
Hepatocytes | 2 | 2015 | 1238 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2019 | 2313 | 0.100 |
Why?
|
Hepatitis C | 1 | 2020 | 1521 | 0.090 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22663 | 0.090 |
Why?
|
Endotoxins | 1 | 2012 | 560 | 0.090 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2012 | 1170 | 0.090 |
Why?
|
Living Donors | 2 | 2022 | 573 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 8896 | 0.070 |
Why?
|
Mice | 8 | 2022 | 80373 | 0.070 |
Why?
|
Cell Communication | 1 | 2012 | 1635 | 0.070 |
Why?
|
Intestines | 1 | 2012 | 1924 | 0.060 |
Why?
|
Models, Animal | 3 | 2016 | 2204 | 0.060 |
Why?
|
Bacteria | 1 | 2012 | 2114 | 0.050 |
Why?
|
Animals | 9 | 2022 | 169404 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 23476 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3824 | 0.050 |
Why?
|
Organ Preservation | 1 | 2022 | 279 | 0.050 |
Why?
|
Vascular Patency | 1 | 2022 | 841 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2020 | 7015 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 1 | 2022 | 527 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2022 | 568 | 0.040 |
Why?
|
Peptides | 1 | 2011 | 4384 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1022 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6730 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2022 | 72473 | 0.040 |
Why?
|
alpha-Fetoproteins | 1 | 2018 | 221 | 0.040 |
Why?
|
Necrosis | 2 | 2013 | 1645 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1273 | 0.040 |
Why?
|
Death | 1 | 2022 | 581 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 12305 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2022 | 5853 | 0.040 |
Why?
|
Tumor Burden | 1 | 2020 | 1900 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1974 | 0.030 |
Why?
|
Cytokines | 3 | 2015 | 7189 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 2015 | 327 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2015 | 15058 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2021 | 4262 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1673 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2022 | 1743 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 2012 | 79 | 0.030 |
Why?
|
Germ-Free Life | 1 | 2012 | 192 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1438 | 0.030 |
Why?
|
Hepacivirus | 1 | 2020 | 1322 | 0.030 |
Why?
|
Cecum | 1 | 2012 | 233 | 0.030 |
Why?
|
Receptors, Pattern Recognition | 1 | 2012 | 77 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 809 | 0.030 |
Why?
|
Male | 9 | 2022 | 350352 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2013 | 490 | 0.030 |
Why?
|
Hepatic Stellate Cells | 1 | 2012 | 120 | 0.030 |
Why?
|
Genes, MHC Class II | 1 | 2012 | 505 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2013 | 602 | 0.020 |
Why?
|
Tissue Donors | 1 | 2020 | 2153 | 0.020 |
Why?
|
Humans | 11 | 2022 | 715818 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3212 | 0.020 |
Why?
|
Cell Death | 1 | 2015 | 1724 | 0.020 |
Why?
|
Metagenome | 1 | 2012 | 402 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2012 | 868 | 0.020 |
Why?
|
Middle Aged | 5 | 2022 | 214666 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29007 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1606 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3753 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1894 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 2802 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2015 | 1703 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 6882 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1581 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1020 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4294 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1939 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2012 | 19905 | 0.020 |
Why?
|
Apoptosis | 2 | 2012 | 9971 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23729 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11689 | 0.020 |
Why?
|
Glycoproteins | 1 | 2012 | 2306 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 62040 | 0.020 |
Why?
|
Survival Rate | 1 | 2018 | 13213 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12460 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4825 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9558 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13643 | 0.010 |
Why?
|
Antigens, CD | 1 | 2012 | 4152 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2013 | 2943 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21795 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2012 | 3424 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4586 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9849 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9809 | 0.010 |
Why?
|
Female | 3 | 2022 | 377229 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39305 | 0.010 |
Why?
|
Adult | 2 | 2022 | 212279 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18197 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10615 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 8047 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 70879 | 0.010 |
Why?
|
Child | 1 | 2022 | 74468 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 11953 | 0.010 |
Why?
|
United States | 1 | 2018 | 67910 | 0.010 |
Why?
|
Aged | 1 | 2020 | 162468 | 0.010 |
Why?
|
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_